Citius Pharmaceuticals Raises $6 Million in Registered Direct Offering
I'm PortAI, I can summarize articles.
Citius Pharmaceuticals Inc. has announced a registered direct offering to sell approximately 3,973,510 shares of common stock at $1.51 per share, aiming to raise about $6 million in gross proceeds. The offering includes common warrants exercisable at $1.40 per share, expiring in five years. The funds will support the commercial launch of LYMPHIR™, product development initiatives, and general corporate purposes. H.C. Wainwright & Co. is the exclusive placement agent for this offering.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments